Start-Up Quarterly Statistics, Q4 2016

30 Jan 2017

• By Deanna Kamienski

A review of biopharma start-up dealmaking and financing from October through December 2016, based on data from Strategic Transactions.

Biopharma start-ups brought in nearly two-and-a-half times as much funding in the fourth quarter as in the third quarter. Novartis AG was one of five big pharma companies to pen an alliance with a new and emerging therapeutics firm; the company also signed an acquisition.

Biopharma start-ups raised a total of $2bn during the final quarter of 2016, which was a significant increase from the...